In his February 16, 2021 Blog, NIH Director Francis Collins summarizes progress to date in treating COVID19 with an antiviral, steroid and monmoclonal antibodies as well as the goals of the above ACTIV clinical trials:
That is a very interesting question, if any of them work, why they work and if the same mechanism is involved in long covid will be something many will try to answer.